C

CCRM

247 employees

CCRM is dedicated to supporting foundational technologies that accelerate the commercialization of stem cell- and biomaterials-based.

Investor insights

Sectors invested in

Biotechnology2
Health Care2
regenerative medicine1
Developer Platform1
Therapeutics1
Medical1
Duchenne1
fracture healing1
biomaterials1
drug conjugate1
bone-graft1
bone-loss1
implants1
brittle bone disease1
osteoporosis1
orphan disease1
bone1
osteogenesis imperfecta1

Funding rounds participated in

$85M sweet spot round size

Most of their 3 investments are in rounds between $85M and $85M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Integration of Science + Business
Non Profit
Cell Manufacturing
Commercial
Association
Cell Reprogramming
Contract Services
Sustainability
Industry Consortium
Biomaterials + Tissue Mimetics
Commercialization
Information Technology

Date founded

2011

Investments made

N

Notch Therapeutics raised $85M on February 10, 2021

Investors: Lumira Ventures, Casdin Capital, LLC, Amplitude Ventures, Samsara BioCapital and CCRM

M

Mesentech raised undisclosed on November 1, 2018

Investors: Réseaux de centres d'excellence, Ontario Public Service, Federal Economic Development Agency for Southern Ontario | Agence fédérale de ... and CCRM

U

Undisclosed raised undisclosed on October 12, 2016

Investors: Lumira Ventures, Accel-Rx - Canada's Health Science Accelerator and CCRM

FAQ